Skip to Main Content

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Name Principal Investigator Institution Study Date Approved Project ID
Bladder Cancer Data Visualization OMAR GALDAMEZ CRUZ CENTRO DE DISEƑO Y COMUNICACION, S.C. PLCO Aug 2, 2022 PLCO-1011
Clarifying the relationship between body mass index and lung cancer using causal inference methods Rajat Das Gupta University of South Carolina PLCO Aug 2, 2022 PLCO-1010
Dietary Intake of Phytoestrogens and Risk of Pancreatic Cancer in the PLCO Trial Chunliang Liu Second Hospital of Shanxi Medical University PLCO Aug 2, 2022 PLCO-1009
A Phase II extension of the use of cg05575921 Methylation to predict risk for lung cancer Robert Philibert Behavioral Diagnostics PLCO Aug 1, 2022 2022-0014
Characterization of serum immuno-oncology biomarker levels in PLCO participants with mosaic chromosomal alterations Mitchell Machiela National Cancer Institute PLCO Aug 1, 2022 2022-0022
Survival Analysis and the Effect of Censoring for Lung Cancer Azar Shahraz AstraZeneca PLCO Jul 22, 2022 PLCO-991
Academic Research using Deep Learning of PLCO's Lung data Zean Liu Harbin Institute of Technology PLCO Jul 22, 2022 PLCO-1008
Deep learning based prognosis prediction for lung cancer patients Danqing Hu Zhejiang lab PLCO Jul 22, 2022 PLCOI-1005
Identification of Risk Factors and Patient Populations at Risk for Developing Cancer of the Head and Neck Jay Piccirillo Washington University School of Medicine in St. Louis PLCO Jul 14, 2022 PLCO-1003
Screening for ovarian cancer in women with a personal or family history of breast or ovarian cancer Nathan Bromham National Institute for Health and Care Excellence PLCO Jul 12, 2022 PLCO-1002
Developing a multi-marker diagnostic test with predictive model enhancements for early-stage (Stage-1) Ovarian cancer Srinagesh Satyanarayana Kaya17 PLCO Jul 1, 2022 PLCO-1000
Expanded Genome-Wide Association Study of Renal Cell Carcinoma Mark Purdue Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health PLCO Jul 1, 2022 PLCO-999
Cancer risk prediction for self evaluation to create cancer awareness Loise Mwarangu Artificial Intelligence Center for Excellence PLCO Jul 1, 2022 PLCO-993
Sharing PLCO oncoarray genotyping and covariate data with the African Ancestry Breast Cancer Consortium Thomas Ahearn Division of Cancer Genetics and Epidemiology, NCI PLCO Jul 1, 2022 PLCO-1001
Deep Predictive Clustering of Irregular Time Series Data for Prostate Cancer Risk and Its Explainability Vanessa Tschichold Norwegian University of Science and Technology PLCO Jun 24, 2022 PLCO-996
A genome wide association study of Helicobacter pylori infection and the causal effect between Helicobacter pylori infection and digestive tract diseases Chuanwen Fan WEST CHINA FOURTH HOSPITAL PLCO Jun 24, 2022 PLCO-989
The association between vitamins intake and cancer risk and mortality of gastrointestinal cancer Chuanwen Fan WEST CHINA FOURTH HOSPITAL PLCO Jun 22, 2022 PLCO-990
Using Machine Learning algorithms to predict breast cancer in women, using Electronic Health Record information. Maya Carswell University Of Liverpool PLCO Jun 22, 2022 PLCO-994
Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk Xuehong Zhang Harvard Medical School PLCO Jun 21, 2022 2022-0002
Analysis of temporal dynamics of pro-inflammatory and anti-inflammatory cytokines during early evolution of ovarian endometrial and lung cancers Anna Lokshin University of Pittsburgh PLCO Jun 21, 2022 PLCO-992